Glintborg, B, Sørensen, I J, Jensen, D V, Steen Krogh, N, Loft, A G, Colic, A, Espesen, J, Olsen, J, Hendricks, O, Grydehøj, J, Jensen Hansen, I M, V.Sørensen, M, Chrysidis, S, Manilo, N, Klarlund, M, Andersen, L S, Nordin, H & Hetland, M L 2016, ' Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis : Results from The Danbio Registry ', Annals of the Rheumatic Diseases, vol. 75, no. Suppl. 2, OP0225, pp. 142 . https://doi.org/10.1136/annrheumdis-2016-eular.1785
Jørgensen, T S, Kristensen, L E, Lorenzen, T, Jensen, J, Zanjani, L, Laursen, T, Butt, S, Dam, M Y, Lindegaard, H M, Espesen, J, Hendricks, O, Kumar, P, Kincses, A, Larsen, L H, Næser, E K, V. Jensen, D, Grydehøj, J, Unger, B, Dufour, N, Sørensen, V N, Vildhøj, S, Jensen Hansen, I M, Raun, J L & Hetland, M L 2013, ' The Prevalence Of Biological Monotherapy Among Rheumatoid Arthritis Patients In Denmark : Results From The Danish Nationwide Danbio Registry ', Arthritis & Rheumatism, vol. 65, 1478 . < http://acrabstracts.org/abstract/the-prevalence-of-biological-monotherapy-among-rheumatoid-arthritis-patients-in-denmark-results-from-the-danish-nationwide-danbio-registry/ >
Publons Joergensen, T S, Kristensen, L-E, Lorenzen, T, Jensen, J, Zanjani, L, Laursen, T, Butt, S, Dam, M Y, Lindegaard, H M, Espesen, J, Hendricks, O, Kumar, P, Kincses, A, Larsen, L H, Andersen, M, Næser, E K, Jensen, D V, Grydehøj, J, Unger, B, Dufour, N, Sørensen, V N, Vildhøj, S, Hansen, I M J, Raun, J & Hetland, M 2013, ' The Prevalence Of Biological Monotherapy Among Rheumatoid Arthritis Patients In Denmark: Results From The Danish Nationwide Danbio Registry. ', Arthritis & Rheumatism, vol. 65, no. S10, 1478, pp. S628 . < http://onlinelibrary.wiley.com/doi/10.1002/art.v65.S10/issuetoc > Web of Science
Web of Science Glintborg, B, Omerovic, E, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Chrysidis, S, Raun, J L, Hendricks, O, Lindegaard, H, Espesen, J, Jakobsen, S, Hansen, I M J, Grydehøj, J, Dalgaard, E, Dalsgaard Pedersen, D, Manilo, N, Andersen, L S, Kristensen, S, Linauskas, A, Krogh, N S & Hetland, M L 2017, ' One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept : – an Observational Study from the Danish Danbio Registry ', The American College of Rheumatology, ACR/ARHP Annual meeting 2017, San Diego, United States, 03/11/2017-08/11/2017 . < http://acrabstracts.org/?post_type=abstracts&s=one-year+clinical+outcomes > Publons Glintborg, B, Omerovic, E, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Chrysidis, S, Lillelund Raun, J, Hendricks, O, Lindegaard, H M, Espesen, J, Jakobsen, S, Jensen Hansen, I M, Grydehøj, J, Dalgaard, E B, Dalsgaard Pedersen, D, Manilo, N, Andersen, L S, Kristensen, S, Linauskas, A, Steen Krogh, N & Hetland, M L 2017, ' One-year clinical outcomes in 1623 patients with inflammatory arthritis who switched from originator to biosimilar Etanercept-an observational study from the Danish Danbio Registry ', Arthritis & Rheumatology, vol. 69, no. Suppl. 10, 1550 . https://doi.org/10.1002/art.40321